From May 10, 2023 to August 31, 2023, the company has repurchased 1,652,174 shares, representing 1.98% for AUD 6.22 million. With this, the company has completed the repurchase of 1,652,174 shares, representing 1.98% for AUD 6.22 million under the buyback announced on May 10, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 AUD | +0.40% | -8.03% | -18.05% |
May. 24 | Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack | MT |
May. 10 | Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.05% | 272M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Tranche Update on Mayne Pharma Group Limited's Equity Buyback Plan announced on May 10, 2023.